Clenbuterol Antibody (1F8B10B7) - BSA Free

• Reactivity: All-NA
• Applications: ELISA, Func
• Clone: 1F8B10B7
• Clonality: Monoclonal
• Host: Mouse
• Conjugate: Unconjugated
• Format: BSA Free
• Concentration: 1 mg/ml

Clenbuterol Antibody (1F8B10B7) - BSA Free Summary

• Immunogen: Clenbuterol-KLH.
• Isotype: IgG1
• Clonality: Monoclonal
• Host: Mouse
• Purity: Protein G purified

Applications/Dilutions

• Dilutions:
  • ELISA 1:10000
  • In vitro assay
• Application Notes: Use In vitro assay reported in scientific literature (Morita K et al).

Packaging, Storage & Formulations

• Storage: Store at 4C short term. Aliquot and store at -20C long term. Avoid freeze-thaw cycles.
• Buffer: PBS
• Preservative: 0.03% Sodium Azide
• Concentration: 1 mg/ml
• Purity: Protein G purified

Alternate Names for Clenbuterol Antibody (1F8B10B7) - BSA Free

• 1-(4-Amino-3,5-dichlorophenyl)-2-(tert-butylamino)ethanol
• 37148-27-9
• 4-Amino-3,5-dichloro-alpha-(((1,1-dimethylethyl)amino)methyl)benzenemethanol
• Clenbuterolum
• NAB 365
• Planipart

Background

Clenbuterol belongs to the group of agonists. In livestock production clenbuterol improves the meat/fat ratio in fattened animals or accelerate the growth. Up to now agonists have not been authorized as adjuvants for fattening. In addition to its lipolytic and anabolic effect, clenbuterol has a relaxing effect on non-striated musculature on which is based its therapeutic use as an antiasthmatic and a tocolytic agent. When employed as a fattening adjuvant, as compared with the therapeutic use, clenbuterol is administered in a 5 to 10 times higher dose. Therefore, it is possible that clenbuterol residues may lead to a risk for consumers after illegal administration.Using the clenbuterol monocalantibody, it is possible to detect clenbuterol and other agonists in urine, muscle and liver both rapidly and with accuracy.

Limitations

This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.

Publications for Clenbuterol Antibody (NB100-2193)(2)

Publications using NB100-2193

• Morita K, Kawaguchi T, et al. Surface plasmon resonance for detecting clenbuterol: Influence of monolayer structure Applied Surface Science. 2015-03-30 (In vitro)
• Hossain MM, Morita K, Kawaguchi T. Effect of Metal Film Thickness and Various Solvents on the SPR Biosensor Sensitivity for Illegal Compound Detection Oriental Journal of chemistry 2018-05-02 (SPR)